Admissions:
None
Delistings:
Today, Ocean Harvest Technology Group (OHT.L) left AIM
What’s baking in the oven?
Potential** Initial Public Offerings:***
Banquet Buffet****
Alkemy Capital Investments 163.75p £16.1m (ALK.L)
The investment company announces that its wholly owned subsidiary Tees Valley Lithium, has now concluded a long-term binding feedstock agreement with Touchstone's Chilean lithium project, one of the world's highest-grade lithium brine deposits. The agreement results in up to 100,000 tonnes of lithium carbonate equivalent secured over an initial 5-year term, with an option to extend for an additional 50,000 tonnes per annum over a further 2 years. First commercial deliveries are expected in 2027.
Catenai 0.275p £3.2m (CTAI.L)
The AIM quoted provider of digital media and technology, announces that, following shareholder approval for the share allotment authorities to complete the fundraise announced on 26 June 2025, it has completed the second tranche of £450k investment into Alludium Ltd as per the announcement of 11 April 2025. Catenai has subscribed for 681,663 ordinary shares in Alludium at a price of 73p per share and, following the Second Investment, holds approximately 13% of the issued share capital of Alludium. The Second Investment includes a bonus share issuance to Catenai equal to 10% of the investment made by the Company as per the terms announced 11 April 2025.
IXICO 11.25p £10.4m (IXI.L)
The neuroscience imaging and biomarker analytics company announced a trading update for the financial year ending 30 September 2025. The Company anticipates revenues to be at least £6.3m, ahead of expectations and representing a 9% increase on 2024 revenues. Further, it is expected that this revenue growth will continue into 2026, moving the Company towards medium term profitability. The Company expects to hold cash of at least £3m at the end of the financial year. Final results for the year ending 30 September 2025 will be announced in December 2025.
MyHealthChecked 12.75p £6.6m (MHC.L)
The consumer home-testing healthcare company announces a supply agreement with Boots UK Ltd. The contract, with an initial term of 12 months, covers a range of lateral flow self-tests and laboratory tests. Comprising eight blood tests, one DNA test, and four lateral flow self-tests, which will be launched by Boots in August 2025. The supply of own branded wellness test into Boots is the results of a strong commercial relationship developed over the last four years.
Orosur Mining Inc 9.15p £29.1m (OMI.L)
The minerals explorer and developer currently operating in Colombia, Argentina and Nigeria, announced an update on the progress of its exploration activities at the Company's flagship Anza Project in Colombia. The Anza Project is now 100% owned by the Company following completion of a Share Purchase Agreement, announced 28th November 2024, whereby the Company purchased all of the shares of its previous JV partner; Minera Monte Aguila. The Project, which is located 50km west of Medellin, is easily accessible and holds infrastructure including water, power and communications as well as a large exploration camp. Assay results from nine additional holes at Pepas have returned strong gold intercepts, including 62.3m @ 12.76 g/t Au (PEP045), 38.5m @ 6.01 g/t Au (PEP044), 53.2m @ 3.36 g/t Au (PEP046), and 31.75m @ 2.01 g/t Au (PEP041).
Sundae Bar 11.5p £47.4m (SBAR.L)
The company developing a platform that serves as a marketplace for AI agents, today announced the launch of 'Scout' an AI Search Assistant Agent designed to streamline agent discovery and matching across the
marketplace. This milestone accelerates the Company's evolution from a directory-based platform to an execution-enabled AI workforce deployment system, delivered ahead of schedule as the Company approaches its platform version 1.0 launch in Q3 2025. Scout has been designed to deliver value across the entire agent discovery and matching process, with key capabilities including Natural-Language Task Matching, Intelligent Agent Recommendations, Gateway Integration.
Technology Minerals 0.14p £3.4m (TM1.L)
The company focused on creating a sustainable circular economy for battery metals, announces that its 48.35% owned battery recycling business, Recyclus Group, through its 100% owned subsidiary LiBatt Recycling Ltd, has jointly secured £8.1m in funding via a consortium with Mint Innovation, Jaguar Land Rover and WMG, University of Warwick. The investment is fifty percent funded by the Department for Business and Trade through the Advanced Propulsion Centre UK, and the balance by the project partners themselves. The project will prove Mint's low-carbon, hydrometallurgical black mass refining technology at demonstration scale, with recycled critical materials such as lithium, nickel and cobalt produced as part of an onshore circular battery supply chain for electric vehicles.
The Artisanal Spirits Company 46p £32.6m (ART.L)
The creator of limited-edition whiskies and experiences around the world, and owner of The Scotch Malt Whisky Society (SMWS), Single Cask Nation (SCN), J.G. Thomson & Artisan Casks announced a trading update for the six months ended 30 June 2025. The Group delivered an adjusted EBITDA loss of £1m, broadly in line with the prior year. Revenue marginally decreased, largely reflecting the c£1m reduction in rephased US shipments vs H1-24, while the company implement their tariff mitigation plan. The company remain focussed on achieving EBITDA in line with expectations.
Pharos Energy 21.45p £88.3m (PHAR.L)
The independent energy company with assets in Vietnam and Egypt, provided a trading and operations update ahead of the Company's Interim Results on 24 September 2025. Group working interest for 1H production was 5,642 boepd net with the 2025 production guidance of 5k-6.2k boepd net remaining unchanged. The Vietnam 1H production is 4.2k boepd while FY25 production guidance is 3.6k - 4.6k boepd net. Egypt 1H production records at 1.5k bopd with FY25 production guidance at 1.4k - 1.6k bopd. Total Group 1H revenue stands at $65.3m with the cash balance at $22.6m alongside a debt free position.
Westminster Group 2.65p £12m (WSG.L)
The supplier of managed services and technology-based security solutions, announced that it has secured an extension contract award valued at an additional circa £1.15m. The contract is an extension to the contract previously announced on 30 June 2025 to provide a Parliamentary Broadcast System for the parliamentary debating chamber of an East African Parliament. The system combines a multimedia conferencing system with broadcast quality IP cameras and audio system for recording and broadcasting parliamentary debates to media outlets and social media platforms.
Status of this Note and Disclaimer
This document has been provided as a general market commentary and is issued to you by Hybridan LLP for information purposes only and should not be construed in any circumstances as investment advice; a recommendation; an offer to sell; nor solicitation of any offer to buy any security or other financial instrument. Nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to such action. The information has been provided without taking into account the investment objective, financial situation or needs of any particular person. Recipients should make their own investment decisions based upon their own financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.
As market commentary, this document is not investment research or a research recommendation for regulatory purposes as it does not constitute substantive research or analysis. It is not subject to any prohibition on dealing ahead of the dissemination of investment research although Hybridan LLP maintains related internal systems and controls in connection with such dealing.
This document should not be relied upon as being an independent or impartial view of the subject matter. The individuals who prepared this document may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result, both Hybridan LLP and the individual members, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.
This document is not intended to be an invitation or inducement to engage in investment activity. In the United Kingdom, this document is directed at and is for distribution only to persons who (i) fall within article 19(5) (persons who have professional experience in matters relating to investments) or article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (SI 2005/1529) (as amended) or (ii) persons who are categorised by Hybridan LLP as either a professional client or eligible counterparty (as those terms are defined in the Financial Conduct Authority's Conduct of Business Sourcebook) (all such persons referred to in (i) and (ii) together being referred to as "relevant persons"). This document must not be acted on or relied up on by persons who are not relevant persons. For the avoidance of doubt, this document is not intended for and should not be relied upon by any person who would be classified as a retail client under the Financial Conduct Authority's Conduct of Business Sourcebook.
The information contained in this document is based on materials and sources that are believed to be reliable; however, they have not been independently verified and are not guaranteed as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. The information may contain projections or other forward-looking statements regarding future events, targets or expectations. There is no assurance that such events or expectations will be achieved, and actual results may be significantly different from that shown here. The information is based on current market conditions, which will fluctuate and may be superseded by subsequent market events or for other reasons. Any and all opinions expressed are current opinions as of the date appearing on this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein.
References to specific securities, asset classes and financial markets are for illustrative purposes only. Past performance is no guarantee of future results. Information and opinions presented have been obtained or derived from sources which Hybridan LLP reasonably believed to be reliable however no representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, directors, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information in this document nor should it be relied upon as such.
To the fullest extent permitted by law, none of Hybridan LLP, its members, directors, officers, employees, agents or associated undertakings shall have any liability whatsoever for any losses arising in any way from use of all or any part of the information in this document including, for the avoidance of doubt, direct or indirect or consequential loss or damage (including lost profits).
Neither this document nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of territorial and/or extra-territorial securities laws, whether in the United Kingdom or any other jurisdiction in any part of the world.
Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication.
In addition, Hybridan LLP, the members, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.
Unless otherwise stated, Hybridan LLP owns the intellectual property rights and any other rights in this document. This document may not be copied, redistributed, resent, forwarded, disclosed or duplicated in any form or by any means, whether in whole or in part other than with the prior written consent of Hybridan LLP.
Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.
This document, which does not constitute research, has been issued by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to any such action. This document has no regard for the specific investment objectives, financial situation or needs of any specific person or entity and is not a personal recommendation to any such person or entity. Recipients should reach an individual investment decision, based upon their respective financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.
The information contained in this document is based on materials and sources that are believed to be reliable; however, such information has not been independently verified and therefore it is not possible to confirm such information as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. No representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information contained in this document, nor should it be relied upon as such.
The content of this document includes market commentary and other information which we have prepared in relation to the company referred to in this document, which is our broking client. The provision of this document to you constitutes a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of Regulation 600/2014/EU (MIFID II Regulation).
Any and all opinions expressed are current as of the date appearing on this face of this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein. To the fullest extent permitted by law, none of Hybridan LLP, its members, officers, employees, agents or associated undertakings shall have any liability whatsoever for any direct or indirect or consequential loss or damage (including lost profits) arising in any way from use of all or any part of the information in this document.
This document should not be relied upon as being an independent or impartial view of the subject matter and, for the avoidance of doubt, constitutes non-independent research (as such term is defined in the Financial Conduct Authority’s Conduct of Business Sourcebook to reflect the requirements of the MIFID II Regulation and Directive 2014/65/EU (known as MIFID II)). The individuals who prepared this document may be interested in shares in the company concerned and/or other companies within its sector, may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result both Hybridan LLP and the individual members, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.
In the United Kingdom, this document is directed at and is for distribution only to persons who (i) fall within article 19(5) (persons who have professional experience in matters relating to investments) or article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (SI 2005/1529) (as amended) or (ii) persons who are each a professional client or eligible counterparty (as those terms are defined in the Financial Conduct Authority’s Conduct of Business Sourcebook) of Hybridan LLP (all such persons referred to in (i) and (ii) together being referred to as relevant persons). This document must not be acted on or relied up on by persons who are not relevant persons. For the purposes of clarity, this document is not intended for and should not be relied upon by any person who would be classified as a retail client under the Financial Conduct Authority’s Conduct of Business Sourcebook.
Neither this document, nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of territorial and/or extra-territorial securities laws, whether in the United Kingdom, the United States or any other jurisdiction in any part of the world.
Where possible this document is made available to all relevant recipients at the same time. Dissemination of research by Hybridan LLP is monitored to ensure that it is only provided to relevant persons. Research prepared by Hybridan LLP is not intended to be received and/or used by any person who is a retail client.
Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication. In addition, Hybridan LLP, the members, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.
This document may not be copied, redistributed, resent, forwarded, disclosed or duplicated in any form or by any means, whether in whole or in part other than with the prior written consent of Hybridan LLP.
MIFID II status of Hybridan LLP research
The cost of production of our corporate research is met by retainers from our corporate broking clients. In addition, from time to time we issue further communications as market commentary (such as our daily newsletter, Small Cap Breakfast), which we consider to constitute a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of the MIFID II Regulation.
Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.
If you would like to unsubscribe, please email enquiries@hybridan.com with “unsubscribe me”.
